Neuroleptic malignant syndrome in a patient with stable dose of olanzapine

Neuroleptic malignant syndrome (NMS), a potentially fatal consequence due to typical neuroleptics, has been described so far. In the past few years, there has been increased use of atypical antipsychotic drugs. Cases of NMS related to atypical neuroleptics, such as olanzapine, are less common in spi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahoo, Manoj Kumar, Kamath, Sangita, Sharan, Abhijeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629885/
https://www.ncbi.nlm.nih.gov/pubmed/29026773
http://dx.doi.org/10.4103/2249-4863.214969
_version_ 1783269140436353024
author Sahoo, Manoj Kumar
Kamath, Sangita
Sharan, Abhijeet
author_facet Sahoo, Manoj Kumar
Kamath, Sangita
Sharan, Abhijeet
author_sort Sahoo, Manoj Kumar
collection PubMed
description Neuroleptic malignant syndrome (NMS), a potentially fatal consequence due to typical neuroleptics, has been described so far. In the past few years, there has been increased use of atypical antipsychotic drugs. Cases of NMS related to atypical neuroleptics, such as olanzapine, are less common in spite of increasing cases reported in literatures. Here, we report a case of NMS in a patient with bipolar affective disorder on maintenance treatment with 5 mg olanzapine for the last 7 year. He was successfully treated with bromocriptine and discharged in stable condition in 10 days.
format Online
Article
Text
id pubmed-5629885
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-56298852017-10-12 Neuroleptic malignant syndrome in a patient with stable dose of olanzapine Sahoo, Manoj Kumar Kamath, Sangita Sharan, Abhijeet J Family Med Prim Care Case Report Neuroleptic malignant syndrome (NMS), a potentially fatal consequence due to typical neuroleptics, has been described so far. In the past few years, there has been increased use of atypical antipsychotic drugs. Cases of NMS related to atypical neuroleptics, such as olanzapine, are less common in spite of increasing cases reported in literatures. Here, we report a case of NMS in a patient with bipolar affective disorder on maintenance treatment with 5 mg olanzapine for the last 7 year. He was successfully treated with bromocriptine and discharged in stable condition in 10 days. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5629885/ /pubmed/29026773 http://dx.doi.org/10.4103/2249-4863.214969 Text en Copyright: © 2017 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Sahoo, Manoj Kumar
Kamath, Sangita
Sharan, Abhijeet
Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
title Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
title_full Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
title_fullStr Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
title_full_unstemmed Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
title_short Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
title_sort neuroleptic malignant syndrome in a patient with stable dose of olanzapine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629885/
https://www.ncbi.nlm.nih.gov/pubmed/29026773
http://dx.doi.org/10.4103/2249-4863.214969
work_keys_str_mv AT sahoomanojkumar neurolepticmalignantsyndromeinapatientwithstabledoseofolanzapine
AT kamathsangita neurolepticmalignantsyndromeinapatientwithstabledoseofolanzapine
AT sharanabhijeet neurolepticmalignantsyndromeinapatientwithstabledoseofolanzapine

Ejemplares similares